Efficacy and safety of adoptive T‐cell therapy in treating cytomegalovirus infections post‐haematopoietic stem cell transplantation: A systematic review and meta‐analysis
Reviews in Medical Virology · 2024-07 · 34 (4)
DOI: 10.1002/rmv.2558 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Reviews in Medical Virology, online erschienen am 15.06.2024. Verfasst von Mohammad Reza Taherian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation, T-Lymphocytes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
Cytomegalovirus (CMV) infection poses significant risks in allogeneic haematopoietic stem cell transplant (allo‐HSCT) recipients. Despite advances in antiviral therapies, issues such as drug resistance, side effects, and inadequate immune reconstitution remain. This systematic review and meta‐analysis aim to evaluate the efficacy and safety of adoptive cell therapy (ATC) in managing CMV infections in allo‐HSCT recipients. Adhering to preferred reporting items for systematic reviews and meta‐analyses guidelines, we conducted a comprehensive database search through July 2023. A systematic review and meta‐analysis were conducted on studies involving HSCT patients with CMV infections treated with ATC. The primary outcome was the response rate to ATC, and secondary outcomes included adverse events associated with ATC. The Freeman–Tukey transformation was applied for analysis. In the meta‐analysis of 40 studies involving 953 participants, ATC achieved an overall integrated response rate of 90.16%, with a complete response of 82.59% and a partial response of 22.95%. ATC source, HLA matching, steroid intake, and age group markedly influenced response rates. Donor‐derived T‐cell treatments exhibited a higher response rate (93.66%) compared to third‐party sources (88.94%). HLA‐matched patients demonstrated a response rate of 92.90%, while mismatched patients had a lower rate. Children showed a response rate of 83.40%, while adults had a notably higher rate of 98.46%. Adverse events were minimal, with graft‐versus‐host disease occurring in 24.32% of patients. ATC shows promising response rates in treating CMV infections post‐HSCT, with an acceptable safety profile. However, to establish its efficacy conclusively and compare it with other antiviral treatments, randomised controlled trials are essential. Further research should prioritise such trials over observational and one‐arm studies to provide robust evidence for clinical decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Student Research Committee, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Medical Physics and Biomedical Engineering, Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
- Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
- Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Mohammad Reza Taherian, Maryam Barkhordar, Alireza Daneshvar
Zitieren
APA
Taherian, M. R., Azarbar, P., Barkhordar, M., Toufani, S., Aliabadi, L. S., Bahri, T., Ahmadvand, M., Yaghmaie, M., Daneshvar, A., & Vaezi, M. (2024). Efficacy and safety of adoptive T‐cell therapy in treating cytomegalovirus infections post‐haematopoietic stem cell transplantation: A systematic review and meta‐analysis. Reviews in Medical Virology, 34(4). https://doi.org/10.1002/rmv.2558
Vancouver
Taherian MR, Azarbar P, Barkhordar M, Toufani S, Aliabadi LS, Bahri T, et al. Efficacy and safety of adoptive T‐cell therapy in treating cytomegalovirus infections post‐haematopoietic stem cell transplantation: A systematic review and meta‐analysis. Reviews in Medical Virology. 2024;34(4). doi:10.1002/rmv.2558
BibTeX
@article{Taherian2024,
author = {Taherian, Mohammad Reza and Azarbar, Pouya and Barkhordar, Maryam and Toufani, Shahin and Aliabadi, Leyla Sharifi and Bahri, Tanaz and Ahmadvand, Mohammad and Yaghmaie, Marjan and Daneshvar, Alireza and Vaezi, Mohammad},
title = {Efficacy and safety of adoptive T‐cell therapy in treating cytomegalovirus infections post‐haematopoietic stem cell transplantation: A systematic review and meta‐analysis},
journal = {Reviews in Medical Virology},
year = {2024},
volume = {34},
number = {4},
doi = {10.1002/rmv.2558}
}
EUVIMED